Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
Wan BA, Lindo L, Mourad YA, Chung S, Forrest D, Kuchenbauer F, Nantel S, Narayanan S, Nevill T, Power M, Rodrigo J, Sanford D, Song K, Stubbins RJ, Sutherland H, Toze CL, White J, Roy C, Hay KA. Wan BA, et al. Among authors: hay ka. Cytotherapy. 2024 May 8:S1465-3249(24)00711-4. doi: 10.1016/j.jcyt.2024.05.009. Online ahead of print. Cytotherapy. 2024. PMID: 38819367 Free article.
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.
Hay KA, Gauthier J, Hirayama AV, Voutsinas JM, Wu Q, Li D, Gooley TA, Cherian S, Chen X, Pender BS, Hawkins RM, Vakil A, Steinmetz RN, Schoch G, Chapuis AG, Till BG, Kiem HP, Ramos JD, Shadman M, Cassaday RD, Acharya UH, Riddell SR, Maloney DG, Turtle CJ. Hay KA, et al. Blood. 2019 Apr 11;133(15):1652-1663. doi: 10.1182/blood-2018-11-883710. Epub 2019 Feb 6. Blood. 2019. PMID: 30728140 Free PMC article. Clinical Trial.
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Hirayama AV, Gauthier J, Hay KA, Voutsinas JM, Wu Q, Gooley T, Li D, Cherian S, Chen X, Pender BS, Hawkins RM, Vakil A, Steinmetz RN, Acharya UH, Cassaday RD, Chapuis AG, Dhawale TM, Hendrie PC, Kiem HP, Lynch RC, Ramos J, Shadman M, Till BG, Riddell SR, Maloney DG, Turtle CJ. Hirayama AV, et al. Blood. 2019 Apr 25;133(17):1876-1887. doi: 10.1182/blood-2018-11-887067. Epub 2019 Feb 19. Blood. 2019. PMID: 30782611 Free PMC article. Clinical Trial.
Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study.
Khalife R, Montroy J, Grigor EJM, Fergusson DA, Atkins H, Seftel M, Presseau J, Thavorn K, Holt RA, Hay K, Lalu MM, Kekre N. Khalife R, et al. Among authors: hay k. Br J Haematol. 2020 Oct;191(1):e14-e19. doi: 10.1111/bjh.16940. Epub 2020 Jul 20. Br J Haematol. 2020. PMID: 32688454 Free article. Clinical Trial. No abstract available.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Stubbins RJ, Stamenkovic M, Roy C, Rodrigo J, Chung S, Kuchenbauer FC, Hay KA, White J, Abou Mourad Y, Power MM, Narayanan S, Forrest DL, Toze CL, Sutherland HJ, Nantel SH, Nevill TJ, Karsan A, Song KW, Sanford DS. Stubbins RJ, et al. Eur J Haematol. 2022 May;108(5):437-445. doi: 10.1111/ejh.13752. Epub 2022 Feb 14. Eur J Haematol. 2022. PMID: 35122325
384 results